JP2021531338A5 - - Google Patents
Info
- Publication number
- JP2021531338A5 JP2021531338A5 JP2021523581A JP2021523581A JP2021531338A5 JP 2021531338 A5 JP2021531338 A5 JP 2021531338A5 JP 2021523581 A JP2021523581 A JP 2021523581A JP 2021523581 A JP2021523581 A JP 2021523581A JP 2021531338 A5 JP2021531338 A5 JP 2021531338A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- dihydropyridine
- pyrazole
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025031155A JP2025098029A (ja) | 2018-07-13 | 2025-02-28 | トロンビン阻害薬、製剤、及びそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862697817P | 2018-07-13 | 2018-07-13 | |
| US62/697,817 | 2018-07-13 | ||
| PCT/US2019/041699 WO2020014669A1 (en) | 2018-07-13 | 2019-07-12 | Thrombin inhibitors, formulations, and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025031155A Division JP2025098029A (ja) | 2018-07-13 | 2025-02-28 | トロンビン阻害薬、製剤、及びそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021531338A JP2021531338A (ja) | 2021-11-18 |
| JP2021531338A5 true JP2021531338A5 (enExample) | 2022-07-20 |
Family
ID=67470750
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523581A Pending JP2021531338A (ja) | 2018-07-13 | 2019-07-12 | トロンビン阻害薬、製剤、及びそれらの使用 |
| JP2025031155A Pending JP2025098029A (ja) | 2018-07-13 | 2025-02-28 | トロンビン阻害薬、製剤、及びそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025031155A Pending JP2025098029A (ja) | 2018-07-13 | 2025-02-28 | トロンビン阻害薬、製剤、及びそれらの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11865110B2 (enExample) |
| EP (1) | EP3820564A1 (enExample) |
| JP (2) | JP2021531338A (enExample) |
| KR (1) | KR20210080347A (enExample) |
| CN (1) | CN113164765B (enExample) |
| AU (1) | AU2019300161B2 (enExample) |
| BR (1) | BR112021000515A2 (enExample) |
| CA (1) | CA3106359A1 (enExample) |
| IL (1) | IL280078B2 (enExample) |
| MX (1) | MX2021000472A (enExample) |
| SG (1) | SG11202100247WA (enExample) |
| WO (1) | WO2020014669A1 (enExample) |
| ZA (1) | ZA202100955B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116735514B (zh) * | 2023-08-11 | 2023-11-03 | 昆明理工大学 | 纳米酶结合液液微萃取快速检测天麻硫熏标志物的方法 |
| WO2025184627A1 (en) * | 2024-03-01 | 2025-09-04 | Cadrenal Therapeutics, Inc. | Method for preventing coagulation in patients with implanted cardiac devices |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5579843A (en) | 1994-08-16 | 1996-12-03 | Loitherstein; Joel S. | Resilient spider for well installation |
| SE9900070D0 (sv) | 1999-01-13 | 1999-01-13 | Astra Ab | New use |
| SI21097A (sl) | 2001-12-04 | 2003-06-30 | Univerza V Ljubljani | Inhibitorji trombina |
| SE0200198D0 (sv) | 2002-01-23 | 2002-01-23 | Astrazeneca Ab | New use |
| AR061996A1 (es) | 2006-07-17 | 2008-08-10 | Boehringer Ingelheim Int | Indicaciones para los inhibidores directos de la trombina en el campo cardiovascular |
| EA201100358A1 (ru) | 2008-08-19 | 2011-10-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Дабигатран для чрескожной хирургической катетеризации сердца |
| US20110190352A1 (en) | 2008-08-19 | 2011-08-04 | Boehringer Ingelheim International Gmbh | Use of dabigatranetexilate for treating patients with pulmonary hypertension |
| WO2010020601A1 (en) | 2008-08-19 | 2010-02-25 | Boehringer Ingelheim International Gmbh | Dabigatran in tumour therapy |
| WO2014145986A1 (en) * | 2013-03-15 | 2014-09-18 | Verseon, Inc. | Multisubstituted aromatic compounds as serine protease inhibitors |
| KR20170048410A (ko) * | 2014-09-17 | 2017-05-08 | 베르선 코포레이션 | 세린 프로테아제 저해제로서의 피라졸릴-치환된 피리돈 화합물 |
-
2019
- 2019-07-12 IL IL280078A patent/IL280078B2/en unknown
- 2019-07-12 MX MX2021000472A patent/MX2021000472A/es unknown
- 2019-07-12 CN CN201980059868.XA patent/CN113164765B/zh active Active
- 2019-07-12 EP EP19745941.5A patent/EP3820564A1/en active Pending
- 2019-07-12 KR KR1020217004016A patent/KR20210080347A/ko not_active Ceased
- 2019-07-12 AU AU2019300161A patent/AU2019300161B2/en active Active
- 2019-07-12 WO PCT/US2019/041699 patent/WO2020014669A1/en not_active Ceased
- 2019-07-12 CA CA3106359A patent/CA3106359A1/en active Pending
- 2019-07-12 BR BR112021000515-3A patent/BR112021000515A2/pt unknown
- 2019-07-12 US US17/259,108 patent/US11865110B2/en active Active
- 2019-07-12 SG SG11202100247WA patent/SG11202100247WA/en unknown
- 2019-07-12 JP JP2021523581A patent/JP2021531338A/ja active Pending
-
2021
- 2021-02-11 ZA ZA2021/00955A patent/ZA202100955B/en unknown
-
2025
- 2025-02-28 JP JP2025031155A patent/JP2025098029A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7407740B2 (ja) | Ｔｌｒ７／ｔｌｒ８阻害剤の結晶形態 | |
| CA2649022C (en) | Cocrystal of c-glycoside derivative and l-proline | |
| AU2019283837B2 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| JP2007504160A5 (enExample) | ||
| JP2010539152A5 (enExample) | ||
| HU229057B1 (en) | Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (-ziprasidone), its preparation and its use as dopamine d2 antagonist | |
| PT1689726E (pt) | Derivados de 5-(benz-(z)-ilideno)-tiazolidin-4-ona como agentes imunossupressores | |
| JP2011509916A5 (enExample) | ||
| JP2010502695A (ja) | 免疫調節薬としてのピリジン−４−イル誘導体 | |
| JP2009541340A5 (enExample) | ||
| WO2001074771A1 (en) | Pyrrole-2,5-dione derivatives for the treatment of diabetes | |
| IL161351A (en) | Activator for PROLIFERATOR-activated prooxisome receptor and medicinal preparations containing it | |
| WO2009055289A2 (en) | Therapeutic substituted lactams | |
| BRPI0616217A2 (pt) | tiazolinonas e oxazolinonas e seus usos como inibidores da ptp1b | |
| JP2024512818A5 (enExample) | ||
| JPH02207070A (ja) | アミノ酸イミド誘導体、それを含有する医薬及び該化合物の製造中間体 | |
| JP2003514893A5 (enExample) | ||
| JP2008520737A5 (enExample) | ||
| JP2016536321A (ja) | カナグリフロジンのｂ形結晶、ｃ形およびｄ形 | |
| WO2020038394A1 (zh) | 吡唑并嘧啶衍生物及其作为pi3k抑制剂的应用 | |
| BRPI0808377B1 (pt) | composto, composição e uso de um composto | |
| CA3019741A1 (en) | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis | |
| BRPI0712025A2 (pt) | derivados de ciclopentano terapÊuticos | |
| CA2754384A1 (en) | Pharmaceutical hypocholesterolemic compositions | |
| JP2006524709A5 (enExample) |